Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
VIDEO: HDAC6 inhibitor shown to be effective migraine treatment
DENVER – Treatment with histone deacetylase 6 inhibitor restored neurol complexities and decreased migraine symptoms, Amynah Pradhan, PhD, said at the American Headache Society’s annual scientific meeting.
VIDEO: Individualized therapy for migraine still needed
DENVER – More data are still needed on proper dosing of patients with eptinezumab for migraine prevention, Rami Apelian, MD, MPH, FAES, said at the American Headache Society’s annual scientific meeting.
Log in or Sign up for Free to view tailored content for your specialty!
FDA committee: Evidence does not support pimavanserin for Alzheimer’s disease psychosis
Acadia Pharmaceuticals Inc. announced the outcome of the FDA advisory committee meeting on the use of pimavanserin for treating hallucinations and delusions associated with Alzheimer’s disease psychosis.
AMA adopts policies addressing child care for physicians
Physicians-in-training have few affordable, accessible options for child care and a lack of paid parental leave, according to the AMA.
Prenatal triptan exposure does not increase ADHD risk in offspring
Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.
VIDEO: Pilot study yields wide range of effective, tolerable verapamil doses for migraine
DENVER — Verapamil was shown to be tolerable for migraine prevention at a maximum dose of 20 mg to 480 mg per day, Yi-Chieh Chen, PharmD, said at the American Headache Society’s annual scientific meeting.
Digital tool aids stroke rehabilitation by tracking arm movements
A sensor-equipped computer program was nearly 80% effective in identifying and counting arm movements in patients undergoing stroke rehabilitation, researchers from NYU Grossman School of Medicine announced.
'They are counting on us': AMA adopts policies to help limit insurance loss
Since the COVID-19 pandemic began, the world has hoped for an end to the public health emergency — but that distinction could also mean millions losing their insurance coverage.
Healio Minute Podcast, Neurology Edition: Top Headlines - Week of June 13, 2022
In this week’s edition, CAR-T ‘robustly effective’ in younger patients with deadly form of brain cancer; SARS-CoV-2 linked to range of neurological diseases; Increased mortality risk for men with type 1 diabetes, regardless of cognitive ability; and more.
VIDEO: Child’s self-report of migraine may differ from diagnostic criteria
DENVER — A child’s understanding of a migraine may not align with diagnostic criteria, highlighting the need for greater transparency in defining “migraine day,” Danielle Kellier, BS, said at the American Headache Society’s annual meeting.
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read